Brief: Augmedix Reports Third Quarter 2022 Financial Results
Nov 14 (Reuters) - Augmedix Inc AUGX.O :
* AUGMEDIX REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
* Q3 REVENUE ROSE 40 PERCENT TO $7.9 MILLION
* CASH, CASH EQUIVALENTS AND RESTRICTED CASH AS OF SEPTEMBER
30,
2022, WAS $27.0 MILLION COMPARED TO $11.1 MILLION AS OF
SEPTEMBER 30, 2021
* QTRLY GAAP NET LOSS WAS $5.5 MILLION
* Q3 REVENUE VIEW $7.8 MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX5R9GnY
Further company coverage: AUGX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Augmedix
See all newsBrief: Augmedix Says Related To Deal With Commure Got Demand Letters
Augmedix Inc reports results for the quarter ended in January - Earnings Summary
Brief: Beryl Capital Management Reports 9.2% Passive Stake In Augmedix
Brief: Augmedix Entered Into A Definitive Agreement To Be Acquired By Commure
Brief: Augmedix Reiterates Second Quarter, Full Year 2024 Outlook